June 9, 2023
Improved control of brain bleeds for patients on FXa inhibitors
Millions of people worldwide depend on Factor Xa inhibitors to manage the risk of blood clotting; however, the medication carries...
Read More
June 6, 2023
First funding by ACT consortium for clinical trials
Five PHRI studies are among the 11 successful applications (out of 43 submitted from across Canada) for funding provided by...
Read More
June 2, 2023
Rainbow Railroad fundraiser
It’s Pride Month, and PHRI employee Andrew Pineau is raising funds for the “Rainbow Railroad” charity that helps LGBTQIA+ people...
Read More
June 1, 2023
PHRI at ESO 2023
PHRI was well-represented at the European Stroke Organisation (ESO) 2023 conference in Munich, Germany May 24-26. PHRI Scientists Mike Sharma, Ashkan...
Read More
May 31, 2023
Next-generation proteomics
PHRI is well positioned to access the latest advances in proteomics. One of our senior scientists, Guillaume Paré, runs the...
Read More
May 22, 2023
HF 2023: Three-year outcomes of PACT-HF
Yesterday at the Heart Failure Association (HFA)’s Heart Failure 2023 Late-Breaking Clinical Trials: Patient Monitoring session, PHRI Scientist Harriette Van...
Read More